prikaz prve stranice dokumenta Cytomegalovirus Seroprevalence and Birth Prevalence of Congenital CMV Infection in Bosnia and Herzegovina : A Single-Center Experience
Rad nije dostupan
Znanstveni rad - Izvorni znanstveni rad
Cytomegalovirus Seroprevalence and Birth Prevalence of Congenital CMV Infection in Bosnia and Herzegovina : A Single-Center Experience
The Pediatric Infectious Disease Journal, 39 (2020), 2; 140-144. https://doi.org/10.1097/inf.0000000000002510
Arapović, Jurica; Rajič, Borko; Pati, Sunil; Brizić, Ilija; Azinović, Igor; Šušak, Božo; Ostojić, Maja; Tutiš, Borka; Raguž, Ana Boban; Tomić, Vajdana; Jonjić, Stipan; Boppana, Suresh

Institucijski repozitorij: Repozitorij Medicinskog fakulteta u Rijeci

Citirajte ovaj rad

Arapović, J., Rajič, B., Pati, S., Brizić, I., Azinović, I., Šušak, B. ... Boppana, S. (2020). Cytomegalovirus Seroprevalence and Birth Prevalence of Congenital CMV Infection in Bosnia and Herzegovina : A Single-Center Experience. The Pediatric Infectious Disease Journal, 39. (2), 140-144. doi: 10.1097/inf.0000000000002510

Arapović, Jurica, et al. "Cytomegalovirus Seroprevalence and Birth Prevalence of Congenital CMV Infection in Bosnia and Herzegovina : A Single-Center Experience." The Pediatric Infectious Disease Journal, vol. 39, br. 2, 2020, str. 140-144. https://doi.org/10.1097/inf.0000000000002510

Arapović, Jurica, Borko Rajič, Sunil Pati, Ilija Brizić, Igor Azinović, Božo Šušak, Maja Ostojić, et al. "Cytomegalovirus Seroprevalence and Birth Prevalence of Congenital CMV Infection in Bosnia and Herzegovina : A Single-Center Experience." The Pediatric Infectious Disease Journal 39, br. 2 (2020): 140-144. https://doi.org/10.1097/inf.0000000000002510

Arapović, J., et al. (2020) 'Cytomegalovirus Seroprevalence and Birth Prevalence of Congenital CMV Infection in Bosnia and Herzegovina : A Single-Center Experience', The Pediatric Infectious Disease Journal, 39(2), str. 140-144. doi: 10.1097/inf.0000000000002510

Arapović J, Rajič B, Pati S, Brizić I, Azinović I, Šušak B, i sur.. Cytomegalovirus Seroprevalence and Birth Prevalence of Congenital CMV Infection in Bosnia and Herzegovina : A Single-Center Experience. The Pediatric Infectious Disease Journal [Internet]. 2020. [pristupljeno 10.11.2024.];39(2):140-144. doi: 10.1097/inf.0000000000002510

J. Arapović, et al., "Cytomegalovirus Seroprevalence and Birth Prevalence of Congenital CMV Infection in Bosnia and Herzegovina : A Single-Center Experience", The Pediatric Infectious Disease Journal, vol. 39, br. 2, str. 140-144, 2020. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:825892. [Citirano: 10.11.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:184:825892
Podaci o radu
Naslov (engleski)Cytomegalovirus Seroprevalence and Birth Prevalence of Congenital CMV Infection in Bosnia and Herzegovina : A Single-Center Experience
AutorJurica Arapović
AutorBorko Rajič
AutorSunil Pati
AutorIlija Brizić
AutorIgor Azinović
AutorBožo Šušak
AutorMaja Ostojić
AutorBorka Tutiš
AutorAna Boban Raguž
AutorVajdana Tomić
AutorStipan Jonjić
AutorSuresh Boppana
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Temeljne medicinske znanosti
Sažetak (engleski)
Background: Congenital cytomegalovirus infection (cCMV) is a leading cause of sensorineural hearing loss (SNHL) and neurodevelopmental disabilities in developed countries. Although high cCMV rates have been reported in populations with high seroprevalence, the cCMV prevalence in low/middle-income countries in Europe has not been defined. Objective: To determine cytomegalovirus (CMV) seroprevalence and the cCMV prevalence in Bosnia and Herzegovina. Methods: Between March 2010 and February 2019, 5222 sera samples from patients seen at the University Clinical Hospital Mostar were tested for CMV IgG. The cord blood samples collected from 2091 infants between July 2011 and January 2013 were analyzed for CMV IgG and CMV DNA. The cCMV prevalence was determined by testing saliva swabs from 1293 infants between November 2015 and October 2016. Results: The overall CMV IgG prevalence was 81.4% (95% confidence interval: 0.8-0.82). Significantly higher prevalence was observed among females (84.9%) than in males (77.0%), and the rate increased from 50.8% in the 1 to 5 years group to 97.7% in the group > 65 years old. Most cord blood samples (2091/1925, 92.1%) were CMV IgG positive, and 2 (0.1%) were CMV DNA positive. Of the 1293 saliva swabs, 8 (0.62% ; 95% confidence interval: 0.3-1.2) were CMV positive. All 8 infected infants had asymptomatic cCMV, and none had SNHL at 18 months of age. Conclusions: In a highly CMV seropositive population, the prevalence of cCMV was lower compared with that reported from other low/middle-income countries populations. None of the infected infants had symptomatic infection or SNHL at 18 months.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaThe Pediatric Infectious Disease Journal
Brojčani podacivol. 39, br. 2, str. 140-144
p-ISSN0891-3668
DOIhttps://doi.org/10.1097/inf.0000000000002510
URN:NBNurn:nbn:hr:184:825892
Datum objave publikacije2020
URL dokumentahttp://bib.irb.hr/1107475
Vrsta resursaTekst
Prava pristupaZatvoreni pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2022-02-15 14:35:35